Skip to main content

$0.120 0.010 (9.09%)

High

$0.12

Low

$0.11

Trades

74

Turnover

$139,612

Volume

1,216,523
30 June 2023 at 4:10pm
Register to track CAN and receive email alerts.

Cann supplies medicinal cannabis for clinical trial

StockBot

416,823 posts

CAN released this announcement to the ASX on 9 March 2021, 9:00. The announcement is not marked as price sensitive, and is 2 page(s) in length and 612.21kb in size.

You can view all announcements from CAN and see how they appear on a price chart on the announcements page.

At the date of this announcement, CAN was 1.080% short sold according to ASIC data. It was ranked the 173rd most shorted stock on the ASX. It remains ranked 643rd as of the latest reported data (04 June 2024).

Other Recent Announcements from CAN
Dr Julian Chick appointed as Deputy Chair 27 June 2023, 8:16
Shareholder and Investor Webinar 26 June 2023, 14:22
Letter to ineligible shareholders 23 June 2023, 8:18
Cann supplies medicinal cannabis for clinical trial 9 March 2021, 9:00
Cann Group - Half yearly investor presentation 22 February 2021, 8:56
Cann releases half-year results - 31 December 2020 22 February 2021, 8:55
Half Yearly Report and Accounts 22 February 2021, 8:54
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track CAN and receive email alerts.